NCT00267137

Study for Atrial Fibrillation Reduction (SAFARI)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 540 (planned)
• Sponsor: Medtronic Cardiac Ablation Solutions · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Atrial fibrillation (AF), which is the name for rapid beats in the upper chambers of the heart, is the world's most common kind of irregular heart beat. People with AF experience symptoms such as heart palpitations (a racing or pounding feeling in the chest), shortness of breath, dizziness, fatigue or weakness. Although AF can occur in otherwise healthy people for no apparent reason, it is sometimes associated with high blood pressure, heart disease or lung problems. The purpose of the SAFARI trial is to study the effectiveness of pacing algorithms in the upper chamber of the heart for patients who have both AF and bradycardia (slow heart beat).

Conditions

• Atrial Fibrillation, Bradycardia

Interventions

Type	Name	Description
DEVICE	Pacing Algorithms

Timeline

• Start date: 2002-09-01
• Primary completion: 2005-09-11
• Completion: 2006-07-21
• First posted: 2005-12-20
• Last updated: 2025-02-13

Locations

34 sites across 1 country: United States